Boehringer Ingelheim Animal Health, a leading provider of medicine for pets, horses and livestock, announced today the appointment of Randolph Legg as its U.S. president.
The Aservo EquiHaler (ciclesonide inhalation spray), an industry first in equine medicine, addresses an unmet need for horses with severe equine asthma.
Boehringer Ingelheim will present five separate $15,000 awards focused on two specific disease topics.
A donation to The Foundation for the Horse and a video honor dedication and care provided by equine veterinarians.
Updated, centralized resources include online neurological exam, interactive EPM diagnostic tool
Providing a “gut check” can help you better diagnose, treat and prevent equine gastric disease.
The annual Boehringer Ingelheim Awards showcase emerging veterinary talent.
Boehringer Ingelheim has sponsored summer vet student learning scholarships for 30 years.
Boehringer Ingelheim Animal Health (BI) has put together a toolkit and video to help horse owners understand diagnosing and treating gastric ulcers.
Boehringer Ingelheim is accepting proposals for the 2018 Advancement in Equine Research Awards for Equine Respiratory Disease Research.
A case of rabies was recently reported in a Bobcat in Munfordville, Kentucky.
Among wild animals, rabies is most often reported in skunks and raccoons but is also found in bats and foxes, and usually is transmitted from the saliva of an infected animal into a bite wound.
Boehringer Ingelheim (BI) has selected three research proposals to fund as part of its 2017 Advancement in Equine Research Award program. Since 2011 BI has given more than $470,000 to advancing the knowledge of equine infectious disease.
Today marks the 10th time that Boehringer Ingelheim has received a perfect score on the Corporate Equality Index (CEI) and has been designated as a 2018 Best Place to Work for LGBTQ Equality.
Boehringer Ingelheim today announced it has been named to Science magazine’s annual list of “top employers” within the pharmaceutical and biotechnology industry for the 13th consecutive year. Boehringer Ingelheim was one of only 20 companies recognized.
Boehringer Ingelheim (BI) and EquiManagement magazine are pleased to announce this year’s Champions of the Cause Award winners, Darla Garon and Hannah Schlanger.
As part of a three-year commitment, Boehringer Ingelheim has become FEI Equine Health Partner and FEI Campus Partner.
Boehringer Ingelheim announced today that for the sixth consecutive year it has been named to Working Mother magazine’s annual 100 Best Companies list.
Travel can significantly increase the risk of a horse contracting an infectious disease.
As the days get shorter and opportunities for equine activities dwindle, the immunity provided by some vaccinations administered earlier in the year may also be diminishing.
Poor performance can stem from a variety of issues; however, there are a few things we know.
Boehringer Ingelheim once again invites public and private researchers studying equine infectious diseases to submit proposals for the 2017 Equine Research Awards.
Boehringer Ingelheim Animal Health (BIAH) is pleased to announce that Surpass (1% diclofenac sodium) is back on the market after a two-year absence.
Veterinary technicians and assistants play a critical role in horse health. To recognize their contributions, Boehringer Ingelheim (BI), EquiManagement magazine, and the American Association of Equine Veterinary Technicians and Assistants (AAEVT) are accepting nominations for the Champions of the Cause Award for the third year. The nomination period will run from April 17, 2017 to July 14, 2017.